invac-1
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2014 (NCT02301754)
Timeline
Indications
Mechanism of action
- Telomerase reverse transcriptaseImmunity, active
TERT immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- invac-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03265717 | Phase 2 | Jul 25, 2018 | Invectys |
| NCT02301754 | Phase 1 | Nov 1, 2014 | Invectys, Keyrus Biopharma, Paris Diderot University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Invectys | For profit | 2 | 2 | 2 | 2014 |
| Keyrus Biopharma | For profit | 1 | 0 | 1 | 2014 |
| Paris Diderot University | Academic/Hospital | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1